Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT
This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 12/01/52) and is published in full in <i>Health Technology Assessment</i>; Vol. 29, No. 5. See the NIHR Funding and Awards website for further award information.
Authors
- Nicholas Jones (ORCID: https://orcid.org/0000-0002-0352-3785)
- Jennifer Hirst (ORCID: https://orcid.org/0000-0002-8416-2159)
- Richard Hobbs (ORCID: https://orcid.org/0000-0001-7976-7172)
- Joy K Rahman (ORCID: https://orcid.org/0009-0000-0512-5062)
- Sam Mort (ORCID: https://orcid.org/0000-0001-6332-4641)
- Jane Wolstenholme (ORCID: https://orcid.org/0000-0001-7493-1850)
- Clare Taylor (ORCID: https://orcid.org/0000-0001-8926-2581)
- Ly‐Mee Yu (ORCID: https://orcid.org/0000-0003-0331-7364)
- Richard J. McManus (ORCID: https://orcid.org/0000-0003-3638-028X)
- Louise Jones (ORCID: https://orcid.org/0000-0002-0519-2334)
Institutions
- University of Oxford (GB)
Publication Details
- Journal
- Health Technology Assessment
- Published
- 2025-03-01
- DOI
- https://doi.org/10.3310/pyft6977
- Citations
- 3
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- Health Technology Assessment Programme